Jump to main content
博士論文

PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor

Persistent ID (NDL)
info:ndljp/pid/12304557
Material type
博士論文
Author
竹田(古賀), 智子
Publisher
-
Publication date
2022-03-23
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
九州大学,博士(医学)
View All

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある学位授与機関のWebサイトやCiNii DissertationsLeave the NDL website. から、本文を自由に閲覧できる場合があります。

Notes on use

Note (General):

PubMed番号 : 34134073

Table of Contents

Provided by:国立国会図書館デジタルコレクションLink to Help Page
  • 2023-12-07 再収集

  • 2023-12-07 再収集

  • 2023-12-07 再収集

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Author/Editor
竹田(古賀), 智子
Publication Date
2022-03-23
Publication Date (W3CDTF)
2022-03-23
Alternative Title
PTPN3は肺神経内分泌腫瘍においてT細胞活性化と直接の癌抑制という2つの効果を持つ新規癌免疫治療の標的となり得る
Contributor
江藤, 正俊
岡本, 勇
中川, 尚志
Degree grantor/type
九州大学
Date Granted
2022-03-23